iBio Inc (IBIO)
2.64
+0.19
(+7.76%)
USD |
NYAM |
Nov 22, 16:00
2.64
0.00 (0.00%)
After-Hours: 20:00
iBio Enterprise Value: 14.05M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 14.05M |
| November 21, 2024 | 12.31M |
| November 20, 2024 | 9.932M |
| November 19, 2024 | 10.30M |
| November 18, 2024 | 9.841M |
| November 15, 2024 | 10.76M |
| November 14, 2024 | 9.566M |
| November 13, 2024 | 11.12M |
| November 12, 2024 | 13.23M |
| November 11, 2024 | 13.29M |
| November 08, 2024 | 13.29M |
| November 07, 2024 | 13.11M |
| November 06, 2024 | 13.38M |
| November 05, 2024 | 14.20M |
| November 04, 2024 | 14.29M |
| November 01, 2024 | 14.29M |
| October 31, 2024 | 13.56M |
| October 30, 2024 | 15.02M |
| October 29, 2024 | 15.48M |
| October 28, 2024 | 16.12M |
| October 25, 2024 | 15.94M |
| October 24, 2024 | 15.48M |
| October 23, 2024 | 14.84M |
| October 22, 2024 | 16.30M |
| October 21, 2024 | 18.13M |
| Date | Value |
|---|---|
| October 18, 2024 | 16.12M |
| October 17, 2024 | 15.94M |
| October 16, 2024 | 15.94M |
| October 15, 2024 | 15.57M |
| October 14, 2024 | 13.65M |
| October 11, 2024 | 13.93M |
| October 10, 2024 | 13.84M |
| October 09, 2024 | 15.85M |
| October 08, 2024 | 12.79M |
| October 07, 2024 | 12.87M |
| October 04, 2024 | 8.812M |
| October 03, 2024 | 9.417M |
| October 02, 2024 | 9.158M |
| October 01, 2024 | 9.935M |
| September 30, 2024 | 9.071M |
| September 27, 2024 | 4.741M |
| September 26, 2024 | 3.618M |
| September 25, 2024 | 2.495M |
| September 24, 2024 | 2.581M |
| September 23, 2024 | 2.754M |
| September 20, 2024 | 3.791M |
| September 19, 2024 | 3.186M |
| September 18, 2024 | 2.210M |
| September 17, 2024 | 2.900M |
| September 16, 2024 | 3.332M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.227M
Minimum
Aug 09 2024
843.20M
Maximum
Jul 20 2020
93.36M
Average
35.21M
Median
Mar 28 2023
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
| Theriva Biologics Inc | -12.68M |
| Oragenics Inc | 2.314M |
| Nanoviricides Inc | 15.36M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.989M |
| Total Expenses (Quarterly) | 4.106M |
| EPS Diluted (Quarterly) | -0.46 |
| Earnings Yield | -251.2% |
| Normalized Earnings Yield | -303.63 |